ALPS Medical Breakthroughs ETF (SBIO)
| Assets | $154.57M |
| Expense Ratio | 0.50% |
| PE Ratio | n/a |
| Shares Out | 2.90M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +107.28% |
| Volume | 43,196 |
| Open | 61.12 |
| Previous Close | 61.37 |
| Day's Range | 61.12 - 63.25 |
| 52-Week Low | 29.90 |
| 52-Week High | 63.25 |
| Beta | 0.77 |
| Holdings | 107 |
| Inception Date | Dec 31, 2014 |
About SBIO
Fund Home PageThe ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is issued by SS&C.
Top 10 Holdings
29.87% of assets| Name | Symbol | Weight |
|---|---|---|
| Apogee Therapeutics, Inc. | APGE | 4.63% |
| CG Oncology, Inc. | CGON | 3.42% |
| Xenon Pharmaceuticals Inc. | XENE | 3.03% |
| Travere Therapeutics, Inc. | TVTX | 3.03% |
| Dianthus Therapeutics, Inc. | DNTH | 2.80% |
| Oruka Therapeutics, Inc. | ORKA | 2.79% |
| Veradermics, Incorporated | MANE | 2.76% |
| Definium Therapeutics, Inc. | DFTX | 2.59% |
| Edgewise Therapeutics, Inc. | EWTX | 2.57% |
| ACADIA Pharmaceuticals Inc. | ACAD | 2.25% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2024 | $1.17346 | Dec 26, 2024 |
| Dec 21, 2023 | $0.07106 | Dec 27, 2023 |
| Dec 19, 2019 | $0.01585 | Dec 27, 2019 |
| Dec 20, 2018 | $0.7841 | Dec 27, 2018 |
| Dec 21, 2017 | $0.57949 | Dec 28, 2017 |
News
Biotech ETF Index Surges 10% After Rebalance
After a sweeping semi-annual rebalance, the biotech index underlying the ALPS Medical Breakthroughs ETF (SBIO) gained over 10% in just six trading days beginning June 18. Key Takeaways: SBIO's underly...
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A
The biotechnology sector has broken out of its multiyear bear market. As macroeconomic headwinds moderate and regulatory environments stabilize, biotech ETFs are surging.
CREATOR TV SPORTS™ UNVEILS CREATOR LINEUP FOR INAUGURAL "CREATOR PICKLEBALL TOUR" AT VIDCON ANAHEIM
NichLmao, Peet Montzingo, DangMattSmith, Merrick Hanna and more to compete in a 16-player tournament produced by Creator TV®, set to premiere on streaming this summer. LOS ANGELES, June 15, 2026 /PRNe...
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect...
Last Week's Top 5 Articles Highlight Areas of Interest, Concern
The leading articles for last week ran the gamut in terms of topics, but suggest investors are still worried about inflation and remain interested in biotech, nuclear energy, and derivatives strategie...
Advacam & Vector Space Biosciences sign Letter of Intent (LOI) to Develop AI Models & CubeSat Payloads for the Space Industry
LA JOLLA, Calif.--(BUSINESS WIRE)---- $SBIO #Advacam--Advacam, provider of radiation detectors that map radiation aboard the International Space Station (ISS) and Vector Space Biosciences (crypto symb...
Vector Space Biosciences (SBIO) Is Now Available for Trading on LBank Exchange
Road Town, Virgin Islands--(Newsfile Corp. - September 24, 2023) - LBank Exchange, a global digital asset trading platform, listed Vector Space Biosciences (SBIO) on September 15, 2023. For all users ...